Role of DEB-TACE Versus c-TACE in Treatment of HCC
NCT05093920
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
Doxorubicin-Eluting Beads
Sponsor
Sohag University